Key result
Female sex was an independent protective factor against fatal or disabling ischemic stroke after left atrial appendage closure compared to male sex (HR 0.100).
Why the study?
Women with NVAF have higher stroke risk and poorer outcomes, but sex differences in the efficacy and safety of left atrial appendage closure have remained elusive.
Does female sex improve clinical outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure?
Cohort (n=395)
No
Does female sex improve clinical outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure?
Hazard Ratio: 0.1
p-value: p=0.041
LAAC is safe and feasible in both sexes, with female sex acting as an independent protective factor against fatal or disabling ischemic stroke post-implantation.
Introduction Women are related to higher stroke risk and poorer outcome after stroke attack in patients with non-valvular atrial fibrillation (NVAF). The sex differences in efficacy and safety after left atrial appendage closure (LAAC) have remained elusive. This retrospective study aimed to investigate the safety, feasibility, and clinical outcomes of LAAC between women and men. Methods From 2014 to 2018, 395 patients who underwent LAAC in our center were enrolled in this retrospective study. Baseline clinical characteristics, procedural parameters, and postoperative follow-up data were collected and compared between women and men. Results The study included 154 women and 241 men. Compared with men, women were older (68.1 ± 7.9 vs. 64.6 ± 8.8, p < 0.01**), with higher CHA2DS2-VASc score (4.0 ± 1.7 vs. 3.0 ± 1.6, p < 0.01**). During the mean follow-up duration of 1,566 days (4.3 years), there were 39 major adverse cardiovascular events (MACE, including 19 cardiovascular or unexplained deaths, 15 ischemic strokes, and 5 major bleedings) recorded in 34 patients. The overall rate of ischemic stroke was 0.9 per 100 patient-years, and the overall rate of MACE was 2.1 per 100 patient-years. The cardiovascular or unexplained death and major bleeding were comparable between women and men. Compared with men, women had lower rates of ischemic stroke, fatal or disabling ischemic stroke, MACE, and fatal or disabling MACE, but none of them reached statistical differences (HR: 0.361, p = 0.099, HR: 0.429, p = 0.276, HR: 0.600, p = 0.170, and HR: 0.621, p = 0.254, respectively). In the adjusted analyses with multivariate Cox regression models, women had a lower fatal or disabling ischemic stroke rate compared with men (HR: 0.100, p = 0.041). Conclusion Left atrial appendage closure was feasible and safe for patients of both genders. The ischemic stroke, cardiovascular or unexplained death, and major bleeding were comparable between women and men. However, women were the independent protective factors against fatal or disabling ischemic stroke after LAAC implantation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a cohort in Non-valvular atrial fibrillation (n=395). Female sex vs. Male sex was evaluated on Fatal or disabling ischemic stroke (HR 0.100, p=0.041). Female sex was an independent protective factor against fatal or disabling ischemic stroke after left atrial appendage closure compared to male sex (HR 0.100).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: